Step 5: Ongoing Support Regular follow-up appointments, dosage adjustments as needed, and direct messaging with your care team keep you on track throughout the program
As discussed earlier, getting rid of GLP-1 nausea often boils down to: changing your eating habits, using anti-nausea remedies like over-the-counter medications or peppermint tea, hydrating between (not during) meals, and staying upright after eating
Key points GLP-1 is a hormone that increases insulin release and prevents the release of too much glucagon, helping manage blood glucose levels in individuals with type 2 diabetes GLP-1 receptor agonists, such as liraglutide and semaglutide, effectively reduce blood glucose levels Semaglutide is more effective than liraglutide at reducing blood sugar levels Tirzepatide is a newer GLP-1 receptor agonist that also mimics the actions of another hormone called GIP, which can also reduce blood sugar levels A randomised controlled trial showed that tirzepatide led to more significant blood sugar reductions than semaglutide across three doses Tirzepatide may be more effective than semaglutide at higher doses, but this needs further investigation Liraglutide and semaglutide are available in the UK and the US, while tirzepatide is only available in the US but is likely to be approved in the UK soon
Interestingly, this approach seems to be more effective for the treatment of patients with advanced cancer (210, 215)
This could mean lowering it if cravings resurface or spacing out injections to reduce costs while maintaining progress
About 38% are motivated by cost savings through dose stretching
